Previous studies have shown beneficial effects of PPARγ activation in several animal models of neurological disease [10], including cerebral ischemia [23], multiple sclerosis [32], Parkinson’s disease [33], and AD [12]. This evidence concerns the gene PPARG and multiple sclerosis.